Načítá se...
Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection
Allogeneic hematopoietic cell transplantation (HCT) is the most established form of cancer immunotherapy and has been successfully applied for the treatment and cure of otherwise lethal neoplastic blood disorders. Cancer immune surveillance is mediated to a large extent by alloreactive T- and natura...
Uloženo v:
| Vydáno v: | Bone Marrow Transplant |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7286200/ https://ncbi.nlm.nih.gov/pubmed/29795435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0218-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|